These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8481908)
41. Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer. Gauvin A; Pinguet F; Culine S; Astre C; Cupissol D; Bressolle F Cancer Chemother Pharmacol; 2002 Jan; 49(1):48-56. PubMed ID: 11855752 [TBL] [Abstract][Full Text] [Related]
42. A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors. Dees EC; Whitfield LR; Grove WR; Rummel S; Grochow LB; Donehower RC Clin Cancer Res; 2000 Oct; 6(10):3885-94. PubMed ID: 11051234 [TBL] [Abstract][Full Text] [Related]
43. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
44. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice. van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431 [TBL] [Abstract][Full Text] [Related]
45. Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative. Pierré A; Pérez V; Léonce S; Boutin JA; Saint-Dizier D; Hautefaye P; Lavielle G; Atassi G Cancer Chemother Pharmacol; 1992; 29(5):367-74. PubMed ID: 1551175 [TBL] [Abstract][Full Text] [Related]
46. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus. von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542 [TBL] [Abstract][Full Text] [Related]
47. [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine]. Tsvetkov FO; Kulikova AA; Devred F; Zerniĭ EIu; Lafitte D; Makarov AA Mol Biol (Mosk); 2011; 45(4):697-702. PubMed ID: 21954603 [TBL] [Abstract][Full Text] [Related]
48. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats. Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163 [TBL] [Abstract][Full Text] [Related]
49. [Antitumor and toxic effects of amotin]. Sedakova LA; Bukharova IK; Treshchalin ID; Syrkin AB Eksp Onkol; 1987; 9(5):76-7. PubMed ID: 3691399 [TBL] [Abstract][Full Text] [Related]
50. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique. Cao X; Tai Y; Sun C; Wang K; Pan Y J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133 [TBL] [Abstract][Full Text] [Related]
51. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid. Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141 [TBL] [Abstract][Full Text] [Related]
53. HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice. Lu W; He LC; Zeng XM J Pharm Biomed Anal; 2008 Jan; 46(1):170-6. PubMed ID: 17889477 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of novel inhibitors of androgen synthesis after intravenous administration in mice. Nnane IP; Njar VC; Brodie AM Cancer Chemother Pharmacol; 2003 Jun; 51(6):519-24. PubMed ID: 12715204 [TBL] [Abstract][Full Text] [Related]
55. Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients. Chung F; Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Tingle M; Ching LM Clin Cancer Res; 2004 Sep; 10(17):5949-56. PubMed ID: 15355928 [TBL] [Abstract][Full Text] [Related]
56. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review). Bhushana Rao KS; Collard MP; Trouet A Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995 [TBL] [Abstract][Full Text] [Related]
57. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine. Variol P; Nguyen L; Tranchand B; Puozzo C Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069 [TBL] [Abstract][Full Text] [Related]
60. Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring. Van Calsteren K; Hartmann D; Van Aerschot L; Verbesselt R; Van Bree R; D'Hooge R; Amant F Neurotoxicology; 2009 Jul; 30(4):647-57. PubMed ID: 19422850 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]